title: [Severe polymyositis with simvastatin use].
abstract: BACKGROUND
  Myotoxicity is the most common adverse reaction of statins, being its frequency less than 0.5%. Mild myopathy reversible after statin withdrawal is the most common event. We present a case of severe polymyositis which was likely to be induced by simvastatin.
  
  
  METHODS
  75 years old man with hypercholesterolemia treated with simvastatin 20 mg/day for 6 months started previous 2 months with proximal limb weakness, dysphagia and myalgias during exercise that did not release after simvastatin withdrawal. Laboratory findings showed increased creatinin kinase (6,010 UI/L), raised aldolase (51 UI/L) and lactic acid dehydrogenase (1,406 UI/L). Muscular biopsy showed abundant inflammatory cell infiltration in perivascular areas, muscle fibre necrosis with miofagocitosis and considerable variation in fibre size, some of them reaching 210 mm. Treatment with cortico esteroids was started and 4 months later clinical remission and nomalization of creatinin kinase was observed.
  
  
  CONCLUSIONS
  Mechanisms of statins induced myotoxicity are not well known. Studies in rats suggest a muscle membrane defect (increased membrane fluidity) and abundant signs of damage (fiber necrosis, hipercontraction) but no cellular infiltrates were seen, pointing to a non inflammatory myopathy which was dose dependent. In our case, and Giordano s et al, the remission of the disease with cortico esteroid therapy and the finding of abundant inflammatory cell infiltration suggest the implication of immunological mechanism and not only a muscle membrane defect.
authors.affiliation: Hospital Universitario La Paz, Madrid, España. garcilasoriesco@hotmail.com
authors.forename: G
authors.initials: G
authors.lastname: Riesco-Eizaguirre
authors.forename: F J
authors.initials: FJ
authors.lastname: Arpa-Gutiérrez
authors.forename: M
authors.initials: M
authors.lastname: Gutiérrez
authors.forename: E
authors.initials: E
authors.lastname: Toribio
mesh_terms: D000368:Aged; D000924:Anticholesteremic Agents / Q000009:adverse effects*; D006801:Humans; D008297:Male; D017285:Polymyositis / Q000139:chemically induced*; D012720:Severity of Illness Index; D019821:Simvastatin / Q000009:adverse effects*
chemical_list: D000924:Anticholesteremic Agents; D019821:Simvastatin